Motion Sickness Treatment Market Expected to Reach $525 Million by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Motion Sickness Treatment Market," The motion sickness treatment market size was valued at $393.70 million in 2021, and is estimated to reach $525 million by 2031, growing at a CAGR of 2.9% from 2022 to 2031.

Motion sickness normally occurs when there is a conflict between different senses and travelers are highly susceptible to motion sickness. Various drugs are available in the market to reduce the susceptibility to motion sickness which includes antihistamines, anticholinergics and others. As the number of people sufferring for motion sickness rises, it increases the demand for treatment medications and thus leads to the expansion of motion sickness treatment market size.

Furthermore, the key market players in industry are upgrading the existing product portfolio with some new innovations, which makes the treatment of conditions easier and comfortable. There is an adoption of advanced technologies for manufacturing of medications, which enhances quality of the product. Similar advancements are witnessed in this field, which is a major motion sickness treatment market trends, propelling the growth of the market.

Furthermore, various factors that are driving the growth of the market are rise in incidences of motion sickness among the population around the globe, advances in manufacturing and development of medications in motion sickness treatment industry, and rise in awareness about motion sickness prevention and treatment medications in population. Moreover, there has been a huge advancement in healthcare sector, owing to increase in research activities carried out by the scientist and researchers in the field of pharmaceuticals

The global motion sickness treatment market analysis is done on the basis of drug class, route of administration, distribution channel and region. On the basis of drug class, the market is segmented into antihistamines, anticholinergics and others. The antihistamines segment dominated the market in terms of revenue in 2021, owing to increase in incidences of motion sickness among the travelling population and presence of key market players that offers antihistaminic generic medications for prevention and treatment of motion sickness.

On the other hand, the anticholinergics segment is anticipated to grow at a fastest rate during the forecast period, as doctors are prescribing anticholinergics on a large scale to those experiencing motion sickness. Moreover, key players such as Baxter is offering branded products in this segment such as Transderm scop which is highly recommended for prevention of motion sickness. This boosts the segment growth and thus increases the motion sickness treatment market size.   

On the basis of route of administration, the market is classified into oral, and others. The oral segment dominated the market in terms of revenue in 2021, as there is a high demand for antihistaminic medications which are mainly available in tablet, capsule and pills dosage form. Furthermore, the key market players in motion sickness treatment industry are focusing on manufacturing activities to launch the generic version of the existing branded oral medications which is further anticipated to boost the market during the forecast period.

On the other hand, the others segment is anticipated to grow at a fastest rate during the forecast period, owing to increase in adoption of scopolamine transdermal patches by the travelers around the globe. In addition, the transdermal patches offer therapeutic effect for about 72 hours with single patch which proves to be convenient for international travelers and hence, has a greater demand in the motion sickness treatment industry.

On the basis of distribution channel, the market is segmented into hospital pharmacies, drug stores & retail pharmacies and online pharmacies. The drug stores & retail pharmacies segment exhibited largest motion sickness treatment market share in terms of revenue in 2021, owing to increase in number of drug stores and pharmacies around the globe, and due to easy availability of OTC medications in the drug store. 

On the other hand, the online pharmacies segment is anticipated to grow at the fastest rate owing to easy accessibility of medications and doors step delivery services. These online pharmacies offer a wide range of medicines and medical products to customers, as they are not limited by physical space in the same way that of the local pharmacies. This makes it easier for patients to find the required medications at the earliest, which is further anticipated to boost the market growth during the forecast period.

Region wise, North America obtained the highest market share in 2021. The rise in number of travelers in this region, including tourist, business clients and others, and presence of major players in motion sickness treatment industry which is indeed a major factor contributing to the growth of the market.

On the other hand, Asia-Pacific is expected to witness highest growth during the motion sickness treatment market forecast period, owing to factors such as rise in investments in manufacturing of high-quality products by major key players, and availability of raw materials for manufacturing of motion sickness medications.

Key findings of the study

• By drug class, the antihistamines segment owned largest motion sickness treatment market share in 2021 in terms of revenue.
• By route of administration, the oral segment dominated the market in 2021 and others segment is anticipated to grow at the highest CAGR during the forecast period.
• By distribution channel, the drug stores & retail pharmacies segment dominated the market in 2021. However, online pharmacies segment is anticipated to grow at the highest CAGR during the forecast period.
• Region wise, North America generated the largest revenue in 2021. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.